German state streamlines clinics to target breast cancer
This article was originally published in Clinica
The German federal state of North Rhine-Westphalia (NRW) has made a decisive move towards improving the care of breast cancer patients, by restricting treatment to specialist breast cancer clinics. As a result, only hospitals which carry out at least 150 breast cancer operations on new patients annually, or at least 100 repeat procedures, and have specialists who personally carry out at least 50 operations per year will be allowed to carry out breast cancer treatment. Hospital departments that fail to fulfil these requirements will either be closed down, or forced to merge with those that do. This would see the number of hospitals carrying out such operations fall from 250 to only 50, with each specialist centre caring for between 360,000-450,000 women.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.